IL297304A - Composition for the treatment of respiratory symptoms and methods thereof - Google Patents
Composition for the treatment of respiratory symptoms and methods thereofInfo
- Publication number
- IL297304A IL297304A IL297304A IL29730422A IL297304A IL 297304 A IL297304 A IL 297304A IL 297304 A IL297304 A IL 297304A IL 29730422 A IL29730422 A IL 29730422A IL 297304 A IL297304 A IL 297304A
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- composition
- methods
- respiratory symptoms
- respiratory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Virology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063009499P | 2020-04-14 | 2020-04-14 | |
PCT/IL2021/050428 WO2021209998A1 (en) | 2020-04-14 | 2021-04-14 | Composition for the treatment of respiratory symptoms and methods thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL297304A true IL297304A (en) | 2022-12-01 |
Family
ID=78084378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL297304A IL297304A (en) | 2020-04-14 | 2022-10-13 | Composition for the treatment of respiratory symptoms and methods thereof |
Country Status (2)
Country | Link |
---|---|
IL (1) | IL297304A (en) |
WO (1) | WO2021209998A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230097100A (en) * | 2020-10-29 | 2023-06-30 | 아우랑제브 나피스 나지 | Compositions and methods for treating acute respiratory failure and/or acute respiratory distress syndrome using tetrahydrocannabinol and compositions containing the same |
-
2021
- 2021-04-14 WO PCT/IL2021/050428 patent/WO2021209998A1/en active Application Filing
-
2022
- 2022-10-13 IL IL297304A patent/IL297304A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2021209998A1 (en) | 2021-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288061A (en) | Compounds and methods for the treatment of covid-19 | |
IL271117B (en) | Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders | |
IL273388A (en) | Compositions and methods for treating and ameliorating respiratory conditions and inflammation of mucosa | |
IL275678A (en) | Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension | |
IL284414A (en) | Methods and compositions for the treatment of fabry disease | |
IL287796A (en) | Compositions and methods for the treatment of atpase-mediated diseases | |
IL308221A (en) | Compositions and methods for the treatment of depression | |
EP4171606A4 (en) | Compositions and methods for the treatment of covid-19 | |
PH12016501371A1 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
IL283469A (en) | Inhalable compositions for use in the treatment of pulmonary diseases | |
IL297304A (en) | Composition for the treatment of respiratory symptoms and methods thereof | |
EP3877383A4 (en) | Compounds and compositions for the treatment of respiratory diseases | |
PT3937949T (en) | Phytoecdysones and the derivatives thereof for use in the treatment of impaired lung function | |
EP3534713A4 (en) | Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases | |
GB202217355D0 (en) | Methods for the prophylaxis and treatment of Covid and Covid-19 | |
PT3911347T (en) | Composition for the treatment and/or prevention of lower urinary tract symptoms | |
SG10201902000YA (en) | Isthmin 1 for treatment of lung inflammation | |
IL311581A (en) | Compositions and methods for the treatment of pcdh19 related disorders | |
IL280868A (en) | Compositions and methods for treatment of acute lung injury | |
AU2018904242A0 (en) | Compounds and compositions for the treatment of respiratory diseases | |
AU2019901150A0 (en) | Compositions and methods of treatment of respiratory tract infections | |
EP3846792A4 (en) | Methods and compositions for treatment of asthma or parkinson's disease | |
GB202110146D0 (en) | Treatment of respiratory conditions | |
AU2019900514A0 (en) | Compositions and methods for treating respiratory diseases | |
EP3890765A4 (en) | Methods and compositions for the treatment of sengers syndrome |